grepafloxacin has been researched along with Pneumococcal Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, AP; Parsons, T; Warner, M | 1 |
Goldsmith, CE; Moore, JE; Murphy, PG | 1 |
Deschilder, I; Liekens, K; Lontie, M | 1 |
Johnson, AP; Stewart, BA; Woodford, N | 1 |
4 other study(ies) available for grepafloxacin and Pneumococcal Infections
Article | Year |
---|---|
Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Sputum; Streptococcus pneumoniae | 1997 |
Pneumococcal resistance in the UK.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Northern Ireland; Ofloxacin; Oxacillin; Penicillin Resistance; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Retrospective Studies; Streptococcus pneumoniae; Tetracycline | 1997 |
In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cephalosporins; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Outpatients; Penicillin G; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Roxithromycin; Streptococcus pneumoniae | 1998 |
Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Deoxyribonucleases, Type II Site-Specific; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Piperazines; Pneumococcal Infections; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Streptococcus pneumoniae | 1999 |